uhn-logo

Our Team

  • York Pei, MD, FRCP(C), FACP, FASN

    Director, Center for Innovative Management for Polycystic Kidney Disease

    York is a staff nephrologist at the University Health Network and a Professor of Medicine at the University of Toronto. He received his research training in Clinical Epidemiology at McMaster University and in Human Molecular Genetics in Toronto. His research program focuses on genetic, genomic, and translational research of hereditary kidney diseases with a major focus on polycystic kidney disease, and is supported by grants from the Kidney Foundation of Canada, Physicians Incorporated Foundation, Polycystic Kidney Disease Foundation (USA), and Canadian Institutes of Health Research. He has published more than 90 peer-reviewed papers and has served on the Editorial Board for the Journal of the American Society of Nephrology and on Grant Review Panels for the Kidney Foundation of Canada, Canadian Institutes of Health Research, and National Institutes of Health, USA. He is currently a member of the Scientific Advisory Committee for the Polycystic Kidney Disease Foundation, USA.

  • Moumita Barua, MD, FRCP(C)

    Associate Director, Center for Innovative Management for Polycystic Kidney Disease

    Moumita is a staff nephrologist at the University Health Network and an Assistant Professor at the University of Toronto. She received her clinical training in nephrology at the University of Toronto and then completed a research fellowship in Genetics of Glomerular Diseases at the Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center in Boston, Massachusetts, USA. She returned to Toronto as the inaugural Hereditary Kidney Disease fellow at University Health Network before joining the Division of Nephrology in July 2015. She is an appointed Scientist within the Advanced Diagnostics division at the Toronto General Research Institute and is experienced in managing patients with polycystic kidney disease.

  • Eran Shlomovitz, MD, FRCP(C), FRCS(C)

    Eran is a staff interventional radiologist and general surgeon at the University Health Network and an Assistant Professor in the Department of Surgery and Department of Medical Imaging at the University of Toronto. He received dual training in Interventional Radiology and General Surgery at the University of Toronto. He also completed a fellowship in minimally invasive gastrointestinal surgery and surgical endoscopy at the Oregon Clinic in Portland, Oregon. His clinical interests include image-guided interventions for the treatment of polycystic kidney disease, non-vascular interventional radiology, and minimally invasive surgery. His research interests include the development, training, and evaluation of hybrid therapeutic techniques.

  • Arash Jaberi MD, FRCPC

    Arash is a staff interventional radiologist at the University Health Network/Mount Sinai Hospital. He received radiology residency training at the University of Ottawa, and subsequently competed his Vascular and Interventional Radiology Fellowship at the University of Toronto, University Health Network/Mount Sinai Hospital sites. His clinical interests include image-guided interventions for the treatment of polycystic kidney disease, interventional oncology, and vascular access. His academic interests include medical education and he is currently pursuing a Masters of Education at OISE University of Toronto.

  • Mostafa Atri, MD, FRCP(C)

    Mostafa is a staff radiologist at the University Health Network and a Professor in the Department Medical Imaging at the University of Toronto. He graduated from Tehran University and did his Radiology residency and fellowship at the U.B.C. and McGill University. He also received a Diploma in Epidemiology at McGill University. He is currently the Academic Head of Abdominal Imaging at the University of Toronto, and the Director of Ultrasound at the University Health Network. His clinical and research interests include ultrasonography, elastography, and cancer imaging.

  • Korosh Khalili, MD, FRCP(C)

    Korosh is a staff radiologist at the University Health Network and an Associate Professor in the Department Medical Imaging at the University of Toronto. He received his clinical and research training in abdominal imaging at the University of Toronto and is currently pursing a MSc in Translational Research at the University of Toronto. His clinical and research interests have been in the fields of kidney and hepatobiliary-pancreas magnetic resonance imaging.  He is currently involved in supervising all kidney and liver volumetric studies in our PKD patients for assessing disease severity.

  • Ioan-Andrei Iliuta, MD, FRCP(C)

    Ioan-Andrei is a clinical research fellow in Hereditary Kidney Disease at the University Health Network. He received his training in internal medicine and nephrology (2015) at Laval University. He is currently completing a MSc in Translational Research at the University of Toronto and a two-year clinical research fellowship in Hereditary Kidney Disease at Toronto General Hospital. He is closely involved in evaluating “foam sclerotherapy” as an experimental approach to reduce kidney and liver volume. He plans to begin his PhD study at the University of Toronto in 2017 focusing on metabolic reprogramming as a novel therapeutic approach in ADPKD.

  • Elsa Guiard, MD

    Elsa is a clinical fellow in Hereditary Kidney Disease at the University Health Network. She received her medical degree at the University of Paris-Sud (Paris, France) in 2004, completed residency training in nephrology (2004-2009) in Paris and a clinical fellowship in nephrology at the European Georges Pompidou Hospital (2009-2012). She was a full-time staff nephrologist at AURA Paris, a dialysis unit in Paris (2012-2016). She will be closely involved in the clinical care of patients with polycystic kidney disease.

  • Matthew Lanktree, MD, PhD, FRCP(C)

    Matthew is completing a post doctoral research and clinical fellowship in heritable kidney diseases including polycystic kidney disease at University Health Network, University of Toronto. Matt completed Internal Medicine residency and Nephrology fellowship (2012-2017) at McMaster University following a combined MD/PhD degree (2005-2012) at University of Western Ontario studying complex disease genetics. Matt began research training during an undergraduate degree (2000-2005) in bioinformatics at University of Waterloo. Matt has received funding from the Canadian Institutes of Health Research, and the American Society of Nephrology, and is a member of the Canadian Kidney Foundation KRESCENT program. Over the last 15 years, Matt has published over 50 articles in high impact journals in genetics and medicine, and has set his goal to work toward improving outcomes for patients with polycystic kidney disease.

  • Marina Pourafkari, MD

    Marina is a clinical research fellow in Polycystic Kidney Disease at the University Health Network. She is a trained radiologist and has received research training in Abdominal Imaging at the University of North Carolina at Chapel Hill back in 2005. She was an academic faculty member in the Department of Radiology, Shahid Beheshti University of Medical Sciences in Tehran, Iran before she recently immigrated to Canada. She is currently a research fellow with a focus on development of better kidney volumetric measurement and novel imaging methods in polycystic kidney disease.

  • Crystal Quist, RN, MPH

    Crystal is the nurse coordinator for the Centre of Innovative Management of PKD at the University Health Network. She received a Bachelor of Science in Nursing from McMaster University and a Master of Public Health from the University of Guelph. She began her career in Nephrology as a staff nurse in the hemodialysis unit of St. Joseph’s Healthcare Centre, Hamilton. Transitioning to a Nurse Educator, she provided clinical expertise and educational support to nursing staff within the Kidney Urinary program. Currently, Crystal liaises with community physicians to optimize PKD clinical care by providing patient education and risk assessment and coordinating the treatment of novel or experimental therapeutics (e.g. Tolvaptan and cyst ablation by foam sclerotherapy). She is passionate about nephrology research and innovation, and strives to provide quality care to her patients.

  • Winnie Chan, BA

    Winnie is a clinical trial coordinator of the Hereditary Kidney Disease Program at the University Health Network. With more than 20 years of clinical research experience in pharmaceutical or peer-reviewed grant-funded studies, she has extensive experience in clinical trials in renal osteodystrophy, cardiovascular complications in chronic kidney disease, diabetic nephropathy, hepatitis and HIV-related nephropathy, as well as multiple studies related to hereditary kidney disease. Her main role includes, but not limited to, preparing research proposals, study budget and contracts, and execute trial protocols. She has also established quality training standards and compliance to standard operating procedures for all research staff.

  • Lily Shi, MD, PhD

    Lily is a post-doctoral research fellow for the Hereditary Kidney Disease program at the University Health Network. She received her medical degree at Shanghai Jiao Tong University School of Medicine (2005), and completed her residency training in internal medicine and nephrology fellowship (2005-2009) in Shanghai Ren Ji Hospital, China. She received her Master’s degree in 2007 for her translational research on early detection of cardiovascular complications in Chronic Kidney Disease, and her PhD degree in 2012 on studying biomarkers and pharmacogenetics in progressive IgA nephropathy. Her major research interests include management of registry-based clinical studies, health economics analysis, and development of novel therapies for polycystic kidney disease.

  • Celine Yu, MSc, MBA

    Celine Yu, MSc, MBA is a drug reimbursement specialist for the Division of Nephrology at the University Health Network. She received her dual degrees from Vancouver Island University. Celine has always enjoyed working with patients. She is well-versed in both public and private reimbursement not only in Ontario but throughout Canada. Working at Shoppers Drug Mart and Innomar Strategies has exposed her to the knowledge with both private and public reimbursement rules and regulations. She has also gained dispensary knowledge from the previous experience, learning the intricacies in billing, filling, and the logistics behind dispensing. Her current role with the Hereditary Kidney Disease program involves liaising with insurance providers, government bodies, and pharmaceutical companies to obtain reimbursement for prescription medications.

  • Nicholas Watson, MSc

    Nicholas is a genetic counsellor affiliated with the Hereditary Kidney Disease program at the University Health Network. He completed his MSc in Molecular Genetics while studying synapse formation in the model organism C. elegans. He subsequently went on to complete an MSc in Genetic Counselling at the University of Toronto. Since graduation, Nicholas has worked on contract in specialized genetics clinics, including metabolic genetics at London Health Sciences Centre and high-risk prenatal genetics at McMaster Children’s Hospital. He is currently employed at Mount Sinai Hospital in the Diagnostic Medical Genetics clinical laboratory as a Genetic Diagnostic Data Specialist, and is involved in result analysis, variant assessment and reporting. Nicholas is certified by the American Board of Genetic Counselling and the Canadian Association of Genetic Counselling and is a faculty member in the Department of Medical Genetics at the University of Toronto. He now counsels patients at Toronto General Hospital in the Hereditary Kidney Disease Clinic.